The FDA in September issued two rejections for spinal muscular atrophy therapies—both linked to manufacturing problems—and ...
A new international study has shown that treating babies with spinal muscular atrophy before symptoms appear can dramatically improve outcomes.Emily ...
Mass food poisoning case has occurred again in Garut Regency, West Java, on Tuesday, September 30, 2025. This time, the ...
Not sure how to bring up a treatment change with your SMA doctor? Learn communication tips, key questions to ask, and a ...
MedPage Today on MSN
Contentious MRI Paper Retracted; Autism Award Winners; Instagram for Neuroanatomy
The authors of a controversial 2022 paper that claimed to measure neuronal activity using functional MRI retracted their work ...
Mother of two, Kasey Mumford, 24, from Warwick, gave birth to her second child, Chester, last August. Her mother’s intuition ...
The Chosun Ilbo on MSN
KAIST Uncovers Huntingtin Protein's Neuronal Skeleton Role
A KAIST research team has discovered that the Huntingtin protein originally plays a critical role in constructing the neuronal skeleton under normal conditions. The findings were published in the ...
Columnist G Shellye Horowitz used to be skeptical of AI, but a recent experience opened her eyes to the tool's potential in ...
Health on MSN
3 Common Signs and Symptoms of Autism in Adults
Symptoms of autism spectrum disorder (ASD) in adults include communication challenges, restricted and repetitive behaviors, ...
Panelists discuss how negative symptoms of schizophrenia differ from positive and cognitive symptoms, explaining that negative symptoms involve withdrawal, flat affect, and poverty of thought rather ...
Emma, a third-grader with big plans for her future, received a groundbreaking treatment at just the right time.
The FDA has issued a Complete Response Letter to Scholar Rock regarding the BLA for apitegromab for the treatment of spinal muscular atrophy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results